Market Recap — April 6, 2026
Recap of insider activity, SEC filings, and market-moving news for April 6, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Luminar Technologies Confirms Liquidation Plan; Equity Holders to Receive No Recovery
Cambium Networks Discloses Going Concern Doubt, Nasdaq Delisting, and Extensive Financial Restatements
Soleno Therapeutics to be Acquired by Neurocrine Biosciences for $2.9 Billion in All-Cash Tender Offer
Hawkeye Systems Secures Critical Financing, Undergoes Board & Executive Overhaul, Averting Going Concern Risk
SWK Holdings Completes Merger with Runway Growth Finance, Delists from Nasdaq
OFA Group Secures $15M RWA Tokenization Contract, Valued Over 1.5x Market Cap
Hologic Secures All Regulatory Approvals for Go-Private Merger, CEO MacMillan to Retire Upon Close
OFA Group Secures $15M RWA Tokenization Contract & Acquires 50% QIKBIM IP for $17.5M
Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 Billion in Cash at $53.00 Per Share
Soleno Therapeutics to be Acquired by Neurocrine Biosciences for $2.9 Billion in All-Cash Deal
Profusa Secures $500K in Deeply Discounted Debt, Proposes $30M Equity-Funded Acquisition for Strategic Pivot
Acquiring Consortium Details $5.5M Equity Commitment and 66% Ownership for $2.17/Share Buyout
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
CFO Purchases Over $500K in Company Stock Following Weak Outlook
CFO Stephen Keller Buys $258K in Shares Following Asset Sale Announcement
Director Makes Substantial Open Market Purchase Following Recent CEO Buy Amidst Drug Trial Setback
President & 10% Owner Buys $153K in Shares Amidst Going Concern Warning
CEO Buys $50K in Shares Following Drug Candidate Failure, Signaling Confidence
CEO Marc Johnson Buys $23,946 in Open Market Shares Amidst Recent Financial Disclosures
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
RA Capital Sells $14.5M in Vor Biopharma Shares Following Recent Financial Disclosures
CFO & President Sells Over $7 Million in Company Stock
Director Sells $1.67M in Shares Due to Margin Call, Signaling Financial Pressure
Lands' End CEO Sells $761K in Shares via WHP Global Tender Offer
Lands' End Officer Sells $515K in Shares as Part of WHP Global Tender Offer
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Luminar Technologies Confirms Liquidation Plan; Equity Holders to Receive No Recovery
Hawkeye Systems Secures Critical Financing, Undergoes Board & Executive Overhaul, Averting Going Concern Risk
SWK Holdings Completes Merger with Runway Growth Finance, Delists from Nasdaq
OFA Group Secures $15M RWA Tokenization Contract, Valued Over 1.5x Market Cap
Hologic Secures All Regulatory Approvals for Go-Private Merger, CEO MacMillan to Retire Upon Close
OFA Group Secures $15M RWA Tokenization Contract & Acquires 50% QIKBIM IP for $17.5M
Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 Billion in Cash at $53.00 Per Share
Profusa Secures $500K in Deeply Discounted Debt, Proposes $30M Equity-Funded Acquisition for Strategic Pivot
Xponential Fitness Initiates Strategic Review to Maximize Shareholder Value, Appoints M&A-Focused Director
Xponential Fitness Initiates Strategic Alternatives Review Amid Shareholder Pressure
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Affiliate Files Another Form 144 to Sell $7.7 Million in Shares, Continuing Recent Liquidation Trend
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.